NIFTY
-1.25  -0.01%
 10564.05
S&P BSE SENSEX
-11.71  -0.03%
 34415.58
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 20-Apr-2018
NSE
0.8    0.13%
Rs. 618.60
 
Days Low
Rs. 608.5
Days High
Rs. 623.15

Open Rs. 617.85
 
52 week Low
Rs. 504
52 week High
Rs.808.95
 
 
Bid :                 618.50 (873)
Offer :        0.00 (0)
BSE
Rs.618.50
1.35    0.22%
on 20-Apr-2018
BSE
1.35    0.22%
Rs. 618.50
 
Days Low
Rs. 608.4
Days High
Rs. 623.5

Open Rs. 617
 
52 week Low
Rs. 503.05
52 week High
Rs.809.45
 
 
Bid :                 618.50 (873)
Offer :        0.00 (0)
NSE
Rs.618.60
0.8    0.13%
 
 
Last Price (Rs.)  618.50 Value  41018611.00
Net Change (Rs.)  1.35 Best Buy  618.50
Volume  66516 Best Sell  0.00
Prev.Close (Rs.)  617.15 Best Quantity  873
Open (Rs.)  617.85 Sell Quantity  0
High (Rs.)  623.15 52-Week High (Rs.)  808.95
Low (Rs.)  608.50 52-Week Low (Rs.)  504.00
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  362383.86
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Currents Investments0.20 0.20 196.40 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 509.35 1222095 81.32 0.00 0.69
Cipla 584.40 470512 172.31 48.22 0.34
Piramal Enterprises 2608.00 470154 879.19 57.93 0.80
Cadila Healthcare 388.00 397212 73.15 60.04 0.82
Biocon 637.25 382350 110.72 24.55 0.16
 
Mutual Funds Holdings
Scheme Name% HoldNo.Shares
HDFC Prudence Fund(G) 1.27 8345200
HDFC Balanced Fund(G) 1.80 6582000
HDFC Equity Fund(G) 1.71 6247526
Aditya Birla SL Frontline Equity Fund(G) 1.58 5490981
HDFC Top 200 Fund(G) 1.41 3632450
 
Quarterly Result
(Rs .in millions)Dec 2017Sep 2017Jun 2017
Net Sales26862.8030738.6021882.90
Operating Profit6980.9010680.705002.60
PBDT6848.8010560.504900.10
Net Profit4443.207528.303073.30
More> 
 
Company News
3/28/2018 12:00:00 AM
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
3/5/2018 12:00:00 AM
Clarification sought from Aurobindo Pharma
3/5/2018 12:00:00 AM
Aurobindo Pharma gets 9 observations from USFDA for Hyderabad unit
More>
 
Ratios
   Earnings Per Share (Rs)29.13 
   Book NAV/Share(Rs)143.99 
   PAT Margin (%)17.45 
   Asset Turnover(x)0.76 
   PER(x)23.18 
   Yield(%)0.37 
   EV/Core EBITDA(x)16.96 
   M Cap / Sales4.12 
   Net Sales Growth(%)4.81 
   PAT Growth(%)4.92 
   Total Debt/Equity(x)0.36 
   Current Ratio(x)1.55 
   Quick Ratio(x)1.00 
   Total Debt/Mcap(x)0.08 
More>